282 related articles for article (PubMed ID: 33687417)
1. Ferroptosis/pyroptosis dual-inductive combinational anti-cancer therapy achieved by transferrin decorated nanoMOF.
Xu R; Yang J; Qian Y; Deng H; Wang Z; Ma S; Wei Y; Yang N; Shen Q
Nanoscale Horiz; 2021 Apr; 6(4):348-356. PubMed ID: 33687417
[TBL] [Abstract][Full Text] [Related]
2. Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis.
Deng H; Zhang J; Yang Y; Yang J; Wei Y; Ma S; Shen Q
ACS Appl Mater Interfaces; 2022 Jun; 14(21):24089-24101. PubMed ID: 35588091
[TBL] [Abstract][Full Text] [Related]
3. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
4. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
6. Metal-Organic Framework-Based Nanomedicines for Ferroptotic Cancer Therapy.
Song Y; Xu X; Wang Z; Zhao Y
Adv Healthc Mater; 2024 Apr; 13(11):e2303533. PubMed ID: 38221753
[TBL] [Abstract][Full Text] [Related]
7. Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.
Yamaguchi Y; Kasukabe T; Kumakura S
Int J Oncol; 2018 Mar; 52(3):1011-1022. PubMed ID: 29393418
[TBL] [Abstract][Full Text] [Related]
8. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
[TBL] [Abstract][Full Text] [Related]
9. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy.
Zhang L; Song A; Yang QC; Li SJ; Wang S; Wan SC; Sun J; Kwok RTK; Lam JWY; Deng H; Tang BZ; Sun ZJ
Nat Commun; 2023 Sep; 14(1):5355. PubMed ID: 37660063
[TBL] [Abstract][Full Text] [Related]
10. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin.
Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y
Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755
[No Abstract] [Full Text] [Related]
11. One Stone Two Birds: Zr-Fc Metal-Organic Framework Nanosheet for Synergistic Photothermal and Chemodynamic Cancer Therapy.
Deng Z; Fang C; Ma X; Li X; Zeng YJ; Peng X
ACS Appl Mater Interfaces; 2020 May; 12(18):20321-20330. PubMed ID: 32293862
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer.
Li Q; Chen L; Dong Z; Zhao Y; Deng H; Wu J; Wu X; Li W
Chem Biol Interact; 2019 Nov; 313():108820. PubMed ID: 31518571
[TBL] [Abstract][Full Text] [Related]
13. Fe
Xu Y; Wang S; Xiong J; Zheng P; Zhang H; Chen S; Ma Q; Shen J; Velkov T; Dai C; Jiang H
Adv Healthc Mater; 2024 Jun; 13(14):e2303839. PubMed ID: 38334034
[TBL] [Abstract][Full Text] [Related]
14. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
[TBL] [Abstract][Full Text] [Related]
15. Recent progress on targeting ferroptosis for cancer therapy.
Xu G; Wang H; Li X; Huang R; Luo L
Biochem Pharmacol; 2021 Aug; 190():114584. PubMed ID: 33915157
[TBL] [Abstract][Full Text] [Related]
16. A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells.
Zhou S; Shang Q; Ji J; Luan Y
ACS Appl Mater Interfaces; 2021 Oct; 13(40):47407-47417. PubMed ID: 34597015
[TBL] [Abstract][Full Text] [Related]
17. Metal-Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells.
Liu Y; Niu R; Zhang X; Zhang B; Chen X; Guo J; Song S; Wang Y; Zhang H; Zhao Y
ACS Nano; 2024 May; 18(19):12386-12400. PubMed ID: 38699808
[TBL] [Abstract][Full Text] [Related]
18. Transferrin-Targeted Cascade Nanoplatform for Inhibiting Transcription Factor Nuclear Factor Erythroid 2-Related Factor 2 and Enhancing Ferroptosis Anticancer Therapy.
Chen W; Xie L; Lv C; Song E; Zhu X; Song Y
ACS Appl Mater Interfaces; 2023 Jun; 15(24):28879-28890. PubMed ID: 37249181
[TBL] [Abstract][Full Text] [Related]
19. Metal-Organic Framework Nanoparticles Induce Pyroptosis in Cells Controlled by the Extracellular pH.
Ploetz E; Zimpel A; Cauda V; Bauer D; Lamb DC; Haisch C; Zahler S; Vollmar AM; Wuttke S; Engelke H
Adv Mater; 2020 May; 32(19):e1907267. PubMed ID: 32182391
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
